Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Conference News CRT 2023

In CABG/PCI Decisions for Left Main Disease, Diabetes ‘Still Matters’

Yael L. Maxwell

March 01, 2023

News Daily News

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

Michael O'Riordan

March 01, 2021

News Daily News

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Michael O'Riordan

December 07, 2020

News Conference News PCR London Valves 2020

No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION

Shelley Wood

November 26, 2020

News Conference News TCT 2020

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

L.A. McKeown

October 17, 2020

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

News Daily News

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Michael O'Riordan

December 20, 2019

News Daily News

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Michael O'Riordan

December 10, 2019

News Daily News

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

Michael O'Riordan

August 14, 2019

News Daily News

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

Michael O'Riordan

April 30, 2019

News Daily News

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

Michael O'Riordan

May 21, 2018

News Daily News

ABSORB II Substudy Digs Into Long-term Arterial Remodeling Following BRS, DES Implantation

Yael L. Maxwell

June 29, 2017

News Conference News SCAI 2017

Bioresorbable Scaffolds: Where Do We Go From Here?

L.A. McKeown

May 15, 2017

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Industry News

Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System

October 05, 2015

News Daily News

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

Yael L. Maxwell

August 26, 2015

News Industry News

New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years

May 19, 2015

News Industry News

New Data From EVOLVE Clinical Program Demonstrate SYNERGY™ Bioabsorbable Polymer Stent Meets Key Performance Endpoints

November 18, 2014

News Conference News AHA 2014

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

November 18, 2014

Advertisement

Top Endovascular News of 2023

In CABG/PCI Decisions for Left Main Disease, Diabetes ‘Still Matters’

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

ABSORB II Substudy Digs Into Long-term Arterial Remodeling Following BRS, DES Implantation

Bioresorbable Scaffolds: Where Do We Go From Here?

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years

New Data From EVOLVE Clinical Program Demonstrate SYNERGY™ Bioabsorbable Polymer Stent Meets Key Performance Endpoints

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content